Kava

Generic Name
Kava
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C14H16O3
CAS Number
9000-38-8
Unique Ingredient Identifier
BOW48C81XP
Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Effect of Kava on Anxiety and Stress in Cancer Survivors

Early Phase 1
Not yet recruiting
Conditions
Anxiety
Stress
Sleep
Kava
Cancer
Depression
Interventions
Dietary Supplement: Placebo
Drug: Kava
First Posted Date
2024-01-19
Last Posted Date
2024-11-05
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
43
Registration Number
NCT06213298

Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava

Phase 2
Recruiting
Conditions
Smoking
Interventions
Drug: Kava
Drug: Placebo
First Posted Date
2021-10-18
Last Posted Date
2024-03-29
Lead Sponsor
University of Florida
Target Recruit Count
80
Registration Number
NCT05081882
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK

Phase 1
Withdrawn
Conditions
Kava on the Metabolism of Nicotine and NNK
Interventions
Drug: Kava
First Posted Date
2018-07-31
Last Posted Date
2020-01-13
Lead Sponsor
University of Florida
Registration Number
NCT03606655

Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

First Posted Date
2004-06-07
Last Posted Date
2012-10-19
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Target Recruit Count
16
Registration Number
NCT00083980
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy